Both HeartMate3TM and HVADTM systems were used across the patient groups, and while there were minor variations in outcomes related to device-specific factors, these did not reach statistical significance in influencing the primary endpoints such as mortality, bleeding complications, or ICU stay duration.
← all excerpts
Different ECLS Pump Configurations for Temporary Right Ventricular Assist Device in LVAD Patients: A Retrospective Case-Control Study.
1
—
—